The application of heparin as anticoagulant, anti-inflammatory and growth factor regulating agent is currently limited by its narrow therapeutic window. Here, we describe the use of chemically crosslinked gelatin hydrogels as delivery platform to achieve the control of heparin release over time. Different hydrogel formulations and two strategies for heparin loading were tested. The synergic electrostatic interactions between heparin and gelatin hydrogels resulted in a sustained release until 60 h, demonstrated by toluidine blue tests. Platelets adhesion was significantly reduced in heparin-loaded hydrogels, thus proving good heparin bioactivity after processing. Our heparin-loaded hydrogels represent a possible valid option to develop coati...
gel containing covalently bound heparin is produced by heating a homogeneous water solution of polyv...
Multicomponent gelatin-methacryloyl (GelMA) hydrogels are regularly adopted for cartilage tissue eng...
Thrombus formation at the surface of blood contacting devices can be prevented by local release of h...
The application of heparin as anticoagulant, anti-inflammatory and growth factor regulating agent is...
Bio-based release systems for pro-angiogenic growth factors are of interest, to overcome insufficien...
Purpose Presently insufficient oxygen and/or nutrient supply in tissue engineered grafts resulting i...
Gelatin hydrogels are used as tissue engineering scaffolds and systems for controlled release due to...
Thermosensitive hydrogels (TSH) were synthesized and investigated as heparin releasing polymers for ...
Heparin-based hydrogels are attractive for cell encapsulation and drug delivery because of the abili...
Chemically cross-linked gelatin–chondroitin sulphate (ChS) hydrogels, impregnated in Dacron, were ev...
Chemically cross-linked gelatin hydrogels are versatile cell-adhesive hydrogel materials that have b...
International audienceA commercial suspension of nanoparticles (Eudragit RS 30D) was used to manufac...
A commercial suspension of nanoparticles (Eudragit RS 30D) was used to manufacture a gel for topical...
Graduation date: 2007Biocompatible hydrogels composed of covalently crosslinked, chemically modified...
dissertationThermosensitive hydrogels (TSH) based on N-isopropyl acrylamide (NiPAAm) were synthesize...
gel containing covalently bound heparin is produced by heating a homogeneous water solution of polyv...
Multicomponent gelatin-methacryloyl (GelMA) hydrogels are regularly adopted for cartilage tissue eng...
Thrombus formation at the surface of blood contacting devices can be prevented by local release of h...
The application of heparin as anticoagulant, anti-inflammatory and growth factor regulating agent is...
Bio-based release systems for pro-angiogenic growth factors are of interest, to overcome insufficien...
Purpose Presently insufficient oxygen and/or nutrient supply in tissue engineered grafts resulting i...
Gelatin hydrogels are used as tissue engineering scaffolds and systems for controlled release due to...
Thermosensitive hydrogels (TSH) were synthesized and investigated as heparin releasing polymers for ...
Heparin-based hydrogels are attractive for cell encapsulation and drug delivery because of the abili...
Chemically cross-linked gelatin–chondroitin sulphate (ChS) hydrogels, impregnated in Dacron, were ev...
Chemically cross-linked gelatin hydrogels are versatile cell-adhesive hydrogel materials that have b...
International audienceA commercial suspension of nanoparticles (Eudragit RS 30D) was used to manufac...
A commercial suspension of nanoparticles (Eudragit RS 30D) was used to manufacture a gel for topical...
Graduation date: 2007Biocompatible hydrogels composed of covalently crosslinked, chemically modified...
dissertationThermosensitive hydrogels (TSH) based on N-isopropyl acrylamide (NiPAAm) were synthesize...
gel containing covalently bound heparin is produced by heating a homogeneous water solution of polyv...
Multicomponent gelatin-methacryloyl (GelMA) hydrogels are regularly adopted for cartilage tissue eng...
Thrombus formation at the surface of blood contacting devices can be prevented by local release of h...